Literature DB >> 30541837

Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Bernadett Papp1,2,3,4, Naeem Motlagh5, Richard J Smindak5, Seung Jin Jang5, Aria Sharma5, Juan D Alonso5, Zsolt Toth1,2,3.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human oncogenic virus, which maintains the persistent infection of the host by intermittently reactivating from latently infected cells to produce viral progenies. While it is established that the replication and transcription activator (RTA) viral transcription factor is required for the induction of lytic viral genes for KSHV lytic reactivation, it is still unknown to what extent RTA alters the host transcriptome to promote KSHV lytic cycle and viral pathogenesis. To address this question, we performed a comprehensive time course transcriptome analysis during KSHV reactivation in B-cell lymphoma cells and determined RTA-binding sites on both the viral and host genomes, which resulted in the identification of the core RTA-induced host genes (core RIGs). We found that the majority of RTA-binding sites at core RIGs contained the canonical RBP-Jκ-binding DNA motif. Subsequently, we demonstrated the vital role of the Notch signaling transcription factor RBP-Jκ for RTA-driven rapid host gene induction, which is consistent with RBP-Jκ being essential for KSHV lytic reactivation. Importantly, many of the core RIGs encode plasma membrane proteins and key regulators of signaling pathways and cell death; however, their contribution to the lytic cycle is largely unknown. We show that the cell cycle and chromatin regulator geminin and the plasma membrane protein gamma-glutamyltransferase 6, two of the core RIGs, are required for efficient KSHV reactivation and virus production. Our results indicate that host genes that RTA rapidly and directly induces can be pivotal for driving the KSHV lytic cycle.IMPORTANCE The lytic cycle of KSHV is involved not only in the dissemination of the virus but also viral oncogenesis, in which the effect of RTA on the host transcriptome is still unclear. Using genomics approaches, we identified a core set of host genes which are rapidly and directly induced by RTA in the early phase of KSHV lytic reactivation. We found that RTA does not need viral cofactors but requires its host cofactor RBP-Jκ for inducing many of its core RIGs. Importantly, we show a critical role for two of the core RIGs in efficient lytic reactivation and replication, highlighting their significance in the KSHV lytic cycle. We propose that the unbiased identification of RTA-induced host genes can uncover potential therapeutic targets for inhibiting KSHV replication and viral pathogenesis.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Kaposi’s sarcoma-associated herpesvirus; RTA; lytic reactivation; primary effusion lymphoma; regulation of gene expression

Mesh:

Substances:

Year:  2019        PMID: 30541837      PMCID: PMC6384073          DOI: 10.1128/JVI.01978-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Authors:  Kyla Driscoll Carroll; Wei Bu; Diana Palmeri; Sophia Spadavecchia; Stephen J Lynch; Salvatore A E Marras; Sanjay Tyagi; David M Lukac
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.

Authors:  M J Glesby; D R Hoover; S Weng; N M Graham; J P Phair; R Detels; M Ho; A J Saah
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

5.  Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.

Authors:  Qiuhua Li; Meilan He; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.

Authors:  Thomas Günther; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

7.  Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization.

Authors:  Wei Bu; Diana Palmeri; Raghu Krishnan; Roxana Marin; Virginie M Aris; Patricia Soteropoulos; David M Lukac
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

8.  Suppressive regulation of KSHV RTA with O-GlcNAcylation.

Authors:  Ying-Chieh Ko; Wan-Hua Tsai; Pei-Wen Wang; I-Lin Wu; Shu-Yu Lin; Yu-Lian Chen; Jen-Yang Chen; Su-Fang Lin
Journal:  J Biomed Sci       Date:  2012-02-02       Impact factor: 8.410

Review 9.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

10.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Authors:  Simon Fishilevich; Ron Nudel; Noa Rappaport; Rotem Hadar; Inbar Plaschkes; Tsippi Iny Stein; Naomi Rosen; Asher Kohn; Michal Twik; Marilyn Safran; Doron Lancet; Dana Cohen
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

View more
  11 in total

1.  Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  Gavin Golas; Juan D Alonso; Zsolt Toth
Journal:  Virology       Date:  2019-07-31       Impact factor: 3.616

2.  A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.

Authors:  Olga Gonzalez-Lopez; Jennifer DeCotiis; Corey Goyeneche; Helena Mello; Bryan Alexis Vicente-Ortiz; Hye Jin Shin; Kyla E Driscoll; Peicheng Du; Diana Palmeri; David M Lukac
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

3.  KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Authors:  Lauren R Combs; Lauren McKenzie Spires; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

4.  Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs.

Authors:  Angela Park; Soohwan Oh; Kyle L Jung; Un Yung Choi; Hye-Ra Lee; Michael G Rosenfeld; Jae U Jung
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

Review 5.  The regulation of KSHV lytic reactivation by viral and cellular factors.

Authors:  Praneet Kaur Sandhu; Blossom Damania
Journal:  Curr Opin Virol       Date:  2021-12-03       Impact factor: 7.090

6.  Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.

Authors:  Nenavath Gopal Naik; Thomas Hong Nguyen; Lauren Roberts; Luke Todd Fischer; Katherine Glickman; Gavin Golas; Bernadett Papp; Zsolt Toth
Journal:  PLoS Pathog       Date:  2020-01-10       Impact factor: 6.823

Review 7.  Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections.

Authors:  Natalie Atyeo; Michelle D Rodriguez; Bernadett Papp; Zsolt Toth
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

8.  Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.

Authors:  Endrit Elbasani; Silvia Gramolelli; Thomas Günther; Ildar Gabaev; Adam Grundhoff; Päivi M Ojala
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 9.  Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease.

Authors:  Jacqueline Fröhlich; Adam Grundhoff
Journal:  Semin Immunopathol       Date:  2020-03-26       Impact factor: 9.623

10.  Contrasting roles for G-quadruplexes in regulating human Bcl-2 and virus homologues KSHV KS-Bcl-2 and EBV BHRF1.

Authors:  Shivani Kumar; Chitteti Ramamurthy; Divya Choudhary; Aashika Sekar; Anupam Patra; Neel Sarovar Bhavesh; Perumal Vivekanandan
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.